학술논문

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome
Document Type
Article
Source
In Blood Advances 25 June 2024 8(12):3092-3108
Subject
Clinical Trials and Observations
Immunobiology and Immunotherapy
Language
ISSN
2473-9529